ST-elevation myocardial infarction with nonobstructive coronary arteries associated with significant mortality
1. Patients with ST-elevation myocardial infarction (STEMI) with nonobstructive coronary arteries...
Read MoreFeb 3, 2024
1. Patients with ST-elevation myocardial infarction (STEMI) with nonobstructive coronary arteries...
Read MoreFeb 3, 2024
1. In two randomized, noninferiority trials, low-dose calcium in pregnant women with low dietary...
Read MoreFeb 3, 2024
1. Higher doses of guideline-medical therapy (GDMT) within 2 weeks after discharge from an acute...
Read MoreFeb 2, 2024
1. In this randomized controlled trial, patients with transthyretin (TTR) amyloid cardiomyopathy...
Read MoreFeb 1, 2024
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read MoreFeb 1, 2024
1. In this randomized controlled trial, apixaban lowered the risk of stroke or systemic embolism...
Read MoreFeb 1, 2024
1. The Atezolizumab group demonstrated significantly greater progression-free and overall survival...
Read MoreFeb 1, 2024
1. Women with non-screen detected ductal carcinoma in situ had worse outcomes for the 25 years...
Read MoreJan 31, 2024
1. Smartphone mental health apps have a small but significant effect on reduction of general...
Read MoreJan 31, 2024
1. Absence of moderate or severe headache 24 hours following administration of treatment drug was...
Read MoreJan 31, 2024
1. There was no procedure-related mortality or life-threatening events reported. 2. At the 6-month...
Read MoreJan 30, 2024
1. The risk of developing the same or any mental health disorder was increased in offspring of...
Read MoreJan 30, 2024
1. While perceived appetite did not differ between study groups, patients receiving mirtazapine...
Read MoreJan 30, 2024
1. Low dose Olanzapine (2.5 mg) demonstrated similar anti-emetic effect to standard dose...
Read MoreJan 30, 2024
1. There was no kidney rejection noted in the cemiplimab for kidney transplant recipients. 2....
Read MoreJan 27, 2024
Among middle-aged and older men with hypogonadism, testosterone treatment did not result in a...
Read MoreJan 27, 2024
1. Interleukin-23 inhibitors had a lower risk of developing paradoxical eczema when treated for...
Read MoreJan 27, 2024
1. Patients in the pembrolizumab plus chemotherapy group reported a significantly greater overall...
Read MoreJan 26, 2024
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read MoreJan 26, 2024
1. Absence of moderate or severe headache 24 hours following administration of treatment drug was...
Read More